Fate Therapeutics

Developer of cellular immuno-therapeutics for the treatment of cancer and immune disorders

placeSan Diego, California, United States calendar_todayFounded 2007 groups181 employees language fatetherapeutics.com

Registered entities

Innovation

79 patent families (30 granted) — focus: Chemistry & metallurgy, Human necessities, Operations & transport; filing pace steady. Cited 11,062 times.

YearFilings
201513
201611
201718
201818
201919
202023
202126
202224
202330
202437
202536
202612

Social engagement

Social engagement: 27.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Polaris Partners, Venrock, Arch Venture Partners, OVP Venture Partners; 1 has since exited.

Investor typeCountShare
Venture capital867%
Private equity217%
Other / undisclosed217%

Hiring activity

Hires periodically

5 roles tracked across 4 of the last 12 months

10 Jun 2026 · Senior Director, Supply Chain · San Diego

29 May 2026 · Director, Regulatory Affairs · San Diego, California

14 May 2026 · Team Lead, Materials Management · San Diego, California

2 Feb 2026 · Senior Manager/Manager, Manufacturing · San Diego

15 Oct 2025 · Director/ Senior Director, Investor Relations · San Diego

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Event
third quarter investor conferences
15 Jun 2026
Leadership hire
Board of Directors
1 Jun 2026
Event
American Society of Clinical Oncology (ASCO) Annual Meeting
Coming soon